BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15652456)

  • 1. Expanding fields of genetically altered cells in head and neck squamous carcinogenesis.
    Braakhuis BJ; Leemans CR; Brakenhoff RH
    Semin Cancer Biol; 2005 Apr; 15(2):113-20. PubMed ID: 15652456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications.
    Braakhuis BJ; Tabor MP; Kummer JA; Leemans CR; Brakenhoff RH
    Cancer Res; 2003 Apr; 63(8):1727-30. PubMed ID: 12702551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second field tumors: a new opportunity for cancer prevention?
    Braakhuis BJ; Brakenhoff RH; Leemans CR
    Oncologist; 2005 Aug; 10(7):493-500. PubMed ID: 16079316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A genetic progression model of oral cancer: current evidence and clinical implications.
    Braakhuis BJ; Leemans CR; Brakenhoff RH
    J Oral Pathol Med; 2004 Jul; 33(6):317-22. PubMed ID: 15200478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased polysomies of chromosomes 7 and 17 during head and neck multistage tumorigenesis.
    Voravud N; Shin DM; Ro JY; Lee JS; Hong WK; Hittelman WN
    Cancer Res; 1993 Jun; 53(12):2874-83. PubMed ID: 8504429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic progression model for head and neck cancer: implications for field cancerization.
    Califano J; van der Riet P; Westra W; Nawroz H; Clayman G; Piantadosi S; Corio R; Lee D; Greenberg B; Koch W; Sidransky D
    Cancer Res; 1996 Jun; 56(11):2488-92. PubMed ID: 8653682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial mutations are a late event in the progression of head and neck squamous cell cancer.
    Mithani SK; Taube JM; Zhou S; Smith IM; Koch WM; Westra WH; Califano JA
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4331-5. PubMed ID: 17671113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Super competition as a possible mechanism to pioneer precancerous fields.
    Rhiner C; Moreno E
    Carcinogenesis; 2009 May; 30(5):723-8. PubMed ID: 19126656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Status of primary tumour surgical margins in squamous head and neck cancer: prognostic implications.
    Bradley PJ; MacLennan K; Brakenhoff RH; Leemans CR
    Curr Opin Otolaryngol Head Neck Surg; 2007 Apr; 15(2):74-81. PubMed ID: 17413406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new marker determining clonal outgrowth.
    Mao L
    Clin Cancer Res; 2002 Jul; 8(7):2021-3. PubMed ID: 12114399
    [No Abstract]   [Full Text] [Related]  

  • 11. Can molecular assessment improve classification of head and neck premalignancy?
    Mao L
    Clin Cancer Res; 2000 Feb; 6(2):321-2. PubMed ID: 10690505
    [No Abstract]   [Full Text] [Related]  

  • 12. Head and neck cancer and precancer: can we use molecular genetics to make better predictions?
    Partridge M
    Ann R Coll Surg Engl; 1999 Jan; 81(1):1-11. PubMed ID: 10325677
    [No Abstract]   [Full Text] [Related]  

  • 13. A disturbance in the force--mitochondrial mutations in squamous cell carcinoma of the head and neck.
    Cohen EE
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4317-9. PubMed ID: 17671110
    [No Abstract]   [Full Text] [Related]  

  • 14. Using tissue adjacent to carcinoma as a normal control: an obvious but questionable practice.
    Braakhuis BJ; Leemans CR; Brakenhoff RH
    J Pathol; 2004 Jun; 203(2):620-1. PubMed ID: 15141375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Squamous cell carcinoma of the upper aerodigestive tract: precursors and problematic variants.
    Wenig BM
    Mod Pathol; 2002 Mar; 15(3):229-54. PubMed ID: 11904340
    [No Abstract]   [Full Text] [Related]  

  • 16. Downregulation of TESTIN and its association with cancer history and a tendency toward poor survival in head and neck squamous cell carcinoma.
    Gunduz E; Gunduz M; Beder L; Nagatsuka H; Fukushima K; Sutcu R; Delibas N; Yamanaka N; Shimizu K; Nagai N
    Arch Otolaryngol Head Neck Surg; 2009 Mar; 135(3):254-60. PubMed ID: 19289703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of precursor cell lines from preneoplastic fields surrounding head and neck cancers.
    van Zeeburg HJ; Graveland AP; Brink A; Nguyen M; Leemans CR; Bloemena E; Braakhuis BJ; Brakenhoff RH
    Head Neck; 2013 Apr; 35(4):568-74. PubMed ID: 22714984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of microsatellite amplifications at chromosomal locus 3q26 as surrogate marker for premalignant changes in mucosa surrounding head and neck squamous cell carcinoma.
    Brieger J; Kastner J; Gosepath J; Mann WJ
    Cancer Genet Cytogenet; 2006 May; 167(1):26-31. PubMed ID: 16682282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second primary tumors (SPT) of head and neck: distinguishing of "true" SPT from micrometastasis by LOH analysis of selected chromosome regions.
    Giefing M; Rydzanicz M; Szukala K; Wozniak A; Wierzbicka M; Szyfter K; Kujawski M
    Neoplasma; 2005; 52(5):374-80. PubMed ID: 16151577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current status of biomarkers in head and neck cancer.
    Chang SS; Califano J
    J Surg Oncol; 2008 Jun; 97(8):640-3. PubMed ID: 18493942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.